nuciferine has been researched along with Fatty Liver in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, L; Gong, F; Guo, X; Lyu, X; Pan, H; Wang, L; Xu, H; Yang, H; Zhu, H | 1 |
| Ding, H; Jiao, R; Kong, L; Li, F; Pan, Y; Wang, W; Wang, Z; Xie, F; Zhao, X | 1 |
| Deng, J; Lai, B; Liu, D; Liu, J; Tuo, X; Wang, N; Xiao, L; Yang, H; Yao, Q; Zhang, C | 1 |
| Feng, R; Guan, C; Guo, F; Li, X; Li, Y; Sun, C; Wang, Y; Yang, X | 1 |
| Gu, S; Li, X; Liu, G; Liu, Y; Mi, Y; Wu, X; Zhang, B | 1 |
5 other study(ies) available for nuciferine and Fatty Liver
| Article | Year |
|---|---|
Distinct AMPK-Mediated FAS/HSL Pathway Is Implicated in the Alleviating Effect of Nuciferine on Obesity and Hepatic Steatosis in HFD-Fed Mice.
Topics: AMP-Activated Protein Kinases; Animals; Aporphines; Diet, High-Fat; Fatty Liver; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Obesity | 2022 |
Nuciferine blocks MIB2-mediated CARD6 polyubiquitination and degradation in the amelioration of high fructose-induced liver lipid accumulation.
Topics: Animals; Fatty Liver; Fructose; Liver; Rats; RNA, Small Interfering | 2023 |
Nuciferine ameliorates hepatic steatosis in high-fat diet/streptozocin-induced diabetic mice through a PPARα/PPARγ coactivator-1α pathway.
Topics: Animals; Aporphines; Diabetes Mellitus, Experimental; Diet, High-Fat; Fatty Liver; Glucose Tolerance Test; Hep G2 Cells; Humans; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; PPAR alpha; Streptozocin; Transcription Factors | 2018 |
Nuciferine prevents hepatic steatosis and injury induced by a high-fat diet in hamsters.
Topics: Animals; Aporphines; Body Weight; Cricetinae; Dietary Fats; Fatty Liver; Feeding Behavior; Gene Expression Regulation; Liver; Male; Mesocricetus; Organ Size; Oxidative Stress; Real-Time Polymerase Chain Reaction; Wounds and Injuries | 2013 |
PLGA nanoparticles for the oral delivery of nuciferine: preparation, physicochemical characterization and in vitro/in vivo studies.
Topics: Administration, Oral; Animals; Aporphines; Chemical Phenomena; Drug Delivery Systems; Fatty Liver; Hep G2 Cells; Humans; Lactic Acid; Male; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Random Allocation; Rats; Rats, Sprague-Dawley | 2017 |